Industri

Innovent licenses IBI355 rights to Spero for up to $1.1bn

IBI355 is an Fc-silent, third-generation anti-CD40L antibody that is expected to...

Dr Batra’s Healthcare launches HairGain with 50 Billion...

Company introduces a non-surgical hair restoration treatment based on exosome t...

Bayer appoints Simon Rosof as Head of Asia Pacific Phar...

Rosof assumes regional leadership role and will also oversee the ASEAN cluster ...

Heena Santry Joins Columbus Office of DLR Group

Heena Santry, MD, MS, MBA ,FACS, EDAC, recently joined the Columbus, Ohio, offic...

Steve Walsh Appointed President, CEO of American Hospit...

The American Hospital Association (AHA) recently announced the appointment of St...

Anti-Viral Flooring by Toli

Hitoe AdVantage by Toli features a refined granular visual designed for the most...

Cellares and Sonoma partner to automate cell therapy ma...

SBT-77-7101 is described as an autologous CAR-Treg cell therapy currently in Pha...

Novartis and Chai Discovery collaborate on antibody ide...

The agreement grants Novartis access to Chai Discovery’s latest AI models, inclu...

RPG Life Sciences partners with Archerchem Healthcare f...

RPG Life Sciences (RPG LS) has partnered with Archerchem Healthcare to launch N...

Emcure consolidates Gennova ownership; Samit Mehta lead...

Emcure Pharmaceuticals announced the consolidation of its shareholding in bioph...

What India and Africa can teach each other on animal he...

Animal health has become one of the defining priorities for agriculture across ...

OneSource Specialty Pharma and Formycon AG announce str...

OneSource Specialty Pharma, a multi-modality specialty pharma CDMO, and Formyco...

Why weight loss cannot be an aesthetic goal

How has the launch of GLP-1 medication disrupted weight loss/obesity care model...

Leiutis marks global milestone with CDSCO approval for ...

Leiutis Pharmaceuticals LLP has announced that the Central Drugs Standard Contr...

Sun Pharma receives South Africa approval for generic s...

Company to launch once-weekly injectable for adults with type 2 diabetes in the...

Cleveland Clinic Advances Systemwide Growth With Main C...

Cleveland Clinic is moving forward on two major capital initiatives that undersc...